Back
Automatically translated version. May contain inaccuracies compared to the original.
🗝🧡🧡🧡🧡🧡🧡
Every year in Ukraine two people die from rabies — an acute disease caused by the rabies virus. Carriers: rodents, predatory mammals — foxes, raccoon dog-like canids, stray dogs, cats, etc. Prevention: control of animal carriers of the pathogen and prevention of rabies development in a person bitten by a rabid animal.
When combating rabies in wild animals, special oral vaccine-baits are placed in forests; when an animal eats one, it acquires immunity.
The State Service of Ukraine on Food Safety and Consumer Protection (Derzprodspozhyvsluzhba) annually purchases vaccine from the sole domestic manufacturer-monopolist — Ukrvetprompostach LLC — in the amount of 550-580 million UAH. At one time vaccination was handled by the state enterprise Ukrvetprompostach, whose director Volodymyr Leonidovych Solodchuk has strong ties within the State Service.
The head of the State Service, S. Tkachuk, and his first deputy, O. Osiyan, personally determine procurement policy and create conditions for access to tenders. It is through their facilitation that the shameful monopoly of a single favorite is maintained.
Prices for the products are currently fixed at record levels. “Rabistar Red” was purchased at the highest price in the Prozorro system with a unit cost of 43,95 — 2016 per dose. The drug “Rabigard” cost 51,27 hryvnias, which is equivalent to 1,17 dollars. The sharp price increases occur with a total absence of competitors able to push the price down.
The cynicism of the scheme is revealed in state veterinary clinics, where these free vaccines are resold to animal owners at inflated rates. Ukrainians are forced to pay twice for a single vial: first with taxes through the budget, and then with their own money out of pocket.
The owners of Ukrvetprompostach LLC became Solodchuk’s son-in-law — Vitaliy Troyanskyi — and his two daughters Olga Troyanska and Hanna Honcharuk. The business is simple: the vaccine is produced by the company BIOVETA A.S. (Czech Republic). Ukrvetprompostach purchases 20 t of vaccine per year for 115 million UAH, repackages the vaccine from 10 liter cans into small capsules/ampoules, and resells it to the State Service.
Net profit 8-10 million dollars per year. Although Ukrvetprompostach LLC reports either losses or almost zero profit (66 thousand UAH). Official revenue of Ukrvetprompostach LLC in 2025: 583 million UAH. All of this is public money. And it has been so for 20 consecutive years.
The most recent criminal proceeding No.42021102010000012 under part 3 of article 191 of the Criminal Code of Ukraine investigated the siphoning of margins from Ukrvetprompostach LLC to shell companies.
But nothing comes of it: investigations are forgotten and proceedings collapse. Perhaps that’s because Solodchuk’s other son-in-law, Serhiy Honcharuk, is an employee of a respectable three-letter office…
💬 ABleaks_bot
💕 Join
Telegram publication
